| Literature DB >> 35036864 |
Manusnan Suriyalaksh1, Celia Raimondi1, Abraham Mains1, Anne Segonds-Pichon1, Shahzabe Mukhtar1, Sharlene Murdoch1, Rebeca Aldunate2, Felix Krueger1, Roger Guimerà3,4, Simon Andrews1, Marta Sales-Pardo4, Olivia Casanueva1.
Abstract
We design a "wisdom-of-the-crowds" GRN inference pipeline and couple it to complex network analysis to understand the organizational principles governing gene regulation in long-lived glp-1/Notch Caenorhabditis elegans. The GRN has three layers (input, core, and output) and is topologically equivalent to bow-tie/hourglass structures prevalent among metabolic networks. To assess the functional importance of structural layers, we screened 80% of regulators and discovered 50 new aging genes, 86% with human orthologues. Genes essential for longevity-including ones involved in insulin-like signaling (ILS)-are at the core, indicating that GRN's structure is predictive of functionality. We used in vivo reporters and a novel functional network covering 5,497 genetic interactions to make mechanistic predictions. We used genetic epistasis to test some of these predictions, uncovering a novel transcriptional regulator, sup-37, that works alongside DAF-16/FOXO. We present a framework with predictive power that can accelerate discovery in C. elegans and potentially humans. CrownEntities:
Keywords: Bioinformatics; Genetics; Genomics
Year: 2021 PMID: 35036864 PMCID: PMC8753122 DOI: 10.1016/j.isci.2021.103663
Source DB: PubMed Journal: iScience ISSN: 2589-0042
Figure 1Wisdom-of-the-crowds gene regulatory network inference pipeline. Main datasets
113 time series transcriptomics datasets obtained from glp-1(e2144)ts long-lived sterile mutants (Figure S1A). We consider two time series lengths: L4 until day 10 time series and a shorter time series from L4 until day 3—the time frame of maximal gene-expression variability, known to improve results of network inferences (Muldoon et al., 2019). We generated randomized time series data by shuffling both the time and gene dimensions. Input variables. We considered three different input variables to NI tools: time series length, regulator set and five different sets of priors as shown (Tables S2 and S17; STAR Methods). Network inference. For each input combination, we ran the three network inference tools: Inferelator, MERLIN + P, and Time-lagged Ordered Lasso (TOL) and obtained 50 gene regulatory networks (GRN). For each GRN, we also obtained the distribution of edge scores from a network inferred from the randomized data. Filtering and consensus. We filtered edges using the distribution of edge scores built from randomized data, and set a cutoff at 5% significance. We then grouped networks based on their edge similarity, and obtained a consensus network per group (9 in total) (Tables S4 andS5). We evaluated all 9 networks and all possible combinations of them using functional data as gold standard (Table S3); and precision fold enrichment (PFE) and area under fold enrichment curve (AUFE) as metrics (Figure S1E; STAR Methods). Final networks. We selected three final GRNs which scored relatively high for both PFE and AUFE. The figure shows the numbers of nodes and edges for each of the selected GRNs (Table S6).
Summary of mechanistically inferred TF-gene, and gene-gene interaction database
| Data source | Data type | Number of unique TFs | Number of TF-gene interactions | Number of TF-gene interactions after ATAC-seq filters | Number of TF-gene interactions applicable to our dataset | Number of final unique TF/gene requlators |
|---|---|---|---|---|---|---|
| modERN CIS-BP Fuxman Bass,2016 | ChiP-seq | 118 | 185,977 | 101,597 | 49,340 | 57 |
| Motif | 202 | 479,330 | 132,732 | 78,260 | 273 | |
| eY1H | 366 | 21,714 | 18,214 | 13,501 | 334 | |
| 495/892 | ||||||
| Knockout experi-ments | RNA-seq/Microarray | 127,480 | 97,900 | 126 | ||
| 621 | ||||||
According to Kudron et al. (2018), C. elegans has 958 predicted TF genes. However, many of these have been classified as RNA-binding or chromatin-remodeling factors, leaving 892 sequence-specific TFs.
Figure 2In vivo and in silico validation of the inferred gene regulatory networks
(A and B)In vivo validation. We knocked down ten regulators selected at random using RNAi expressing bacteria from larval stage 4 (STAR Methods). We calculated PCC between the relative change in expression levels of regulator and target pairs (ddCt) obtained from at least six independent biological replicates. We considered an interaction correctly predicted in vivo when the size of its PCC is higher than corresponding PCC cutoff values. (A) Mean proportion of correctly predicted interactions of the final 3 networks as a function of Pearson's correlation (PCC) size cutoff. (B) Correctly predicted in vivo interactions for each regulator. Each dot represents the PCC of the ddCt values between one target and one knockdown regulator (Xaxis). The red lines indicate the PCC cut-off (PCC≥ |0.75|). At the top, we show the proportion of correctly predicted interactions per regulator (Table S7).
(C) In silico validation of network topology. We compared structural modules in the GRNs to five empirical gene modules, obtained from RNA-seq datasets specific to glp-1(e2144)ts (Table S9; main text, STAR Methods). For each one of the GRNs, we display the maximum robust Z-scores of Jaccard similarity index between each empirical module and a structural module. A significant robust Z score (robust Z score> 1.96, pvalue of 0.05 based on a right-tailed Fisher's exact test) indicates that an empirical module was recovered by a structural module. The right most plot summarizes the number of empirical gene modules recovered by each inferred network and modules recovered by randomizing gene membership to structural modules with the same number of genes.
Figure 3The global organization of the gene-regulation network reveals an input-core-output structure with aging modulators at its core
(A) Global organization of the network and GO enrichment for each structural module. Each node represents a module. We obtained modules using a Bayesian model selection approach with hierarchical stochastic block models (Table S8; STAR Methods). The area of the nodes is proportional to the number of genes it comprises (shown in b); edge thickness is proportional to its weight (we only represent edges with weight >260-- see STAR Methods for a table of edges). The network has three main layers: input, core and output. We list novel aging regulators in each module; we include daf-16 and age-1 (red) for reference. Boxes show GO enrichment terms of the regulators in each module following the color code of the network nodes (P: Process, (F) Function, (C) Component).
(B) Number of genes in each module. Bars follow the same color code of nodes in (A). Gray bars show network totals.
(C) Number of regulators, number of regulators with a human orthologue and number of regulators in GenAge.
(D) Number of known essential genes in glp-1 C. elegans (Table S11) that appear as regulators in the network.
(E) Number of tested and confirmed aging genes in the second screen (see text). ∗,∗∗ show enrichment with respect to the random expectation of hits given the number of non-GenAge regulators in each module (∗ pvalue <0.1, ∗∗ pvalue <0.05).
(F) Number of regulating genes that cause defects in body morphology (from Kamath and Ahringer, 2003). These results are for the largest consensus GRN (max AUFE) and are consistent with the results of the other networks (Figures S3 and S4).
Figure 4Two-step RNAi screening uncovers 50 novel modulators of the germline longevity pathway, many of them conserved in human and involved in the modulation of wild type lifespan
(A) Normalized percentage of survival at day 16 (D16) of adulthood for glp-1(e2144)ts;rrf-3 worms grown in the presence of RNAi from larval stage 1 (L1). Data has been normalized to the survival of glp-1(e2144)ts at D16 of adulthood fed with bacteria expressing an empty vector (L4440) which corresponds to ∼50% survival (Table S10). Blue dots indicate knockdown of genes which have previously been linked to aging according to GenAge.
(B) Two-step screening strategy and summary of the results. The left gray box depicts the first screen (A) where 1016 regulators were tested--48% of them are already classified as aging genes (GenAge). Among the genes which showed significant glp-1(e2144)ts;rrf-3 lifespan changes and were not in GenAge, 93 candidates with largest change were re-screened using high-resolution lifespan assays (pink box). The second screen monitored worms at twelve time points in triplicate (STAR Methods). Numbers indicate the number of genes following the color code of the boxes.
(C) Normalized mean survival for glp-1(e2144)ts;rrf-3 worms treated with RNAi from L1 stage. Mean survival was calculated by averaging the percentage of survival at D19 of adulthood of three biological replicates. Normalization was relative to the mean survival of control animals fed with bacteria expressing L4440 at D19 adulthood. pvalues were calculated using a logrank test for each replicate and combined using Fisher's method. Bonferroni was applied for multiple comparison correction (Table S12).
(D) The pie chart represents the proportion of genes in the 50 newly-discovered aging genes with a human orthologue and/or a human disease linkage.
(E) Correlation between the rank of normalized mean survival of glp-1(e2144)ts;rrf-3 worms and fem-3(q20) treated with bacteria expressing 50 dsRNAs from L1 stage. (Table S14A). We ranked genes according to the mean percentage of survival of long-lived glp-1(e2144)ts at D19, and the mean percentage of survival of normal lived fem-3(q20)ts at day 13 (D13). The RNAi conditions correspond to the novel aging genes. We used Spearman's ⍴ to quantify the correlation between the ranked lists of genes (⍴=0.742, pvalue <2 x 10−9).
Novel aging genes
| Name | Human orthologue | Human disease | Molecular function | % Lifespan change at D19 | χ2-adjusted |
|---|---|---|---|---|---|
| Attf-3 | High mobility group (HMG) | HMG/Chromatin remodeling | −45.96 | 1.65E-50 | |
| f33h1.4 | Uncharacterized | −45.96 | 9.11 × 10−48 | ||
| Attf-6 | High mobility group | HMG/Chromatin remodeling | −45.96 | 8.59 × 10−44 | |
| Gei-3 | CIC | Yes | Transcriptional repressor | −44.38 | 2.38 × 10−32 |
| b0261.1 | BDP1 | TF | −43.33 | 5.64 × 10−25 | |
| f23b12.7 | CEBPZ | DNA binding | −42.07 | 2.59 × 10−21 | |
| Lin-13 | ZNF423; ZNF462; and ZNF786. | Yes | Zinc finger protein | −41.94 | 1.10 × 10−29 |
| Pqm-1 | Sal-like protein 2 | TF | −41.9 | 1.14 × 10−15 | |
| Hmg-1.2 | HMGB1, HMGB3 | Yes | HMG | −41.53 | 1.10 × 10−19 |
| Taf-5 | TAF-5 | TATA box TF | −41.06 | 1.04 × 10−28 | |
| Daf-16 | FOXO (CONTROL) | Yes | TF | −40.09 | 4.21 × 10−35 |
| b0336.3 | RBM26 | RNA binding | −39.53 | 3.92 × 10−21 | |
| Lin-35 | RBL1; RBL2 | Yes | Transcriptional corepressor | −35.8 | 3.89 × 10−19 |
| Gei-17 | PIAS2; PIAS3, STAT 4 | TF | −34.55 | 7.61 × 10−16 | |
| Erm-1 | EZR, MSN, RDX | Yes | Ezrin-radixin-moesin protein | −34.52 | 1.01 × 10−13 |
| c27a12.2 | ZNF791 | Yes | Zinc finger protein | −33.3 | 3.46 × 10−12 |
| Sdc-3 | CPA3 (A3); CPA4; CPB2 | Yes | Carboxypeptidase | −32.63 | 2.98 × 10−7 |
| f26a10.2 | ZBTB32; ZFP91-CNTF | Yes | TF | −31.57 | 4.51 × 10−14 |
| Isw-1 | SMARCA1 (SWI/SNF related) | Predicted to be TF | −29.18 | 5.04 × 10−13 | |
| Swsn-7 | ARID2 | Yes | Chromatin remodeling | −24.35 | 3.46 × 10−7 |
| Nfyc-1 | NFYC | TF | −15.5 | 1.79 × 10−4 | |
| Sup-37 | Uncharacterized | −13.74 | 1.32 × 10−14 | ||
| y56a3a.18 | ZNF593 | Zinc finger protein | −7.531 | 2.19 × 10−6 | |
| Zgpa-1 | ZGPAT | Zinc finger protein | 8.194 | 1.32 × 10−2 | |
| Zip-3 | ATF5 | TF | 14.23 | 6.06 × 10−4 | |
| r12 × 102.7 | Uncharacterized | 16.05 | 4.49 × 10−2 | ||
| Ahcy-1 | AHCY | Yes | Adenosyl-hydrolase | 16.24 | 2.69 × 10−2 |
| Ztf-3 | Zinc finger protein 394 | Zinc finger protein | 17.51 | 3.93 × 10−6 | |
| Mgl-2 | GRM1 and GRM5 | Yes | Glutamate receptor | 19.19 | 1.48 × 10−5 |
| d2005.6 | Membrane-associating domain; and Marvel domain | 20.18 | 1.83 × 10−7 | ||
| Ham-2 | PRDM16 | Zinc finger protein | 20.24 | 4.83 × 10−3 | |
| Lin-36 | DNA and metal ion binding | 20.78 | 2.43 × 10−3 | ||
| Tkt-1 | Uncharacterized (CONTROL) | Transketolase | 21.01 | 1.09 × 10−7 | |
| Swsn-4 | SMARCA2 | Yes | SWI/SNF-chromatin remodeling | 21.05 | 5.00 × 10−4 |
| c04f5.9 | Zinc finger protein 319 | Zinc finger protein | 21.13 | 2.28 × 10−3 | |
| Sox-4 | SRY | Yes | Sox protein | 21.54 | 4.00 × 10−2 |
| Hmbx-1 | HMBOX1 | Homeobox TF | 21.86 | 6.44 × 10−4 | |
| Nhr-120 | HNF4A; NR2C2 RXRB | Yes | TF | 22.97 | 4.05 × 10−4 |
| c01f6.9 | ZNF706 | Zinc finger protein | 23.83 | 2.79 × 10−4 | |
| Dnj-11 | DNAJC2 | Hsp40 | 24.06 | 2.15 × 10−3 | |
| Dmd-9 | Isoform 1 of Doublesex- and mab-3-related transcription factor 2 | DNA binding TF | 24.49 | 6.50 × 10−4 | |
| Nhr-47 | Isoform HNF4-Alpha-8 of Hepatocyte nuclear factor 4-alpha | TF | 24.58 | 3.83 × 10−2 | |
| Nhr-84 | Nuclear receptor subfamily 2 group E member 1 | TF | 24.99 | 3.90 × 10−3 | |
| Sop-2 | Polycomb protein | 25.22 | 1.85 × 10−2 | ||
| Ztf-14 | GLIS1; GLIS3; ZXDA | Yes | Zinc finger protein | 26.38 | 1.99 × 10−9 |
| Somi-1 | Uncharacterized | 26.79 | 5.76 × 10−8 | ||
| Nra-2 | Ncln | Nicalin | 27.38 | 2.88 × 10−3 | |
| Nhr-7 | Uncharacterized | TF | 27.39 | 2.93 × 10−3 | |
| Nhr-193 | HNF4-Alpha-2 | TF | 28.08 | 2.82 × 10−6 | |
| Age-1 | PIK3CA, PIK3CD (CONTROL) | Yes | Kinase | 30.07 | 1.05 × 10−13 |
| Hmg-1.1 | High mobilty group | Chromatin remodeling | 30.68 | 1.58 × 10−7 | |
| Nduf-6 | NDUFS6 | Ubiquinone oxidoreductase | 31.34 | 7.48 × 10−8 | |
| c34b2.8 | NDUFA13 | Yes | Ubiquinone oxidoreductase | 33.87 | 2.02 × 10−15 |
We list the novel aging genes, its human orthologues, human disease linkage, their known function, and mean lifespan change at day 19 of adulthood upon knockout in glp-1(ts) animals. pvalues from the logrank survival statistical test on 3 independent biological values were combined using Fisher's method and adjusted using Bonferroni correction (Table S12). TF: transcription factor. Although pqm-1 has been shown to be involved in the ILS pathway (Tepper et al., 2013), it is missing in GenAge and has not been described in glp-1(ts). daf-16, age-1, and tkt-1 are shown as controls. Table S13 lists other controls which also match expected results.
Figure 5Global characterization of the novel aging genes reveals genes sharing the same metabolic features and pathways as DAF-16/FOXO and ILS
(A) Comparison of the in vivo fluorescence measures of sod-3p:GFP versus dhs-3p::dhs-3::GFP in glp-1ts animals at day 4 of adulthood. dhs-3p::dhs-3::GFP is a translational reporter which localizes to the intestinal lipid droplets (LD). sod-3p:GFP is a transcriptional reporter for the expression of superoxide dismutase 3 (sod-3), a direct target of DAF-16. Colors correspond to lifespan phenotype as shown in the figure. L4440 is the control/empty vector (Table S15).
(B) Novel aging genes sharing known aging and metabolism targets with daf-16 and age-1. The top panel shows Venn diagrams of the number of shared targets of 6 novel aging genes with age-1 (red) and daf-16 (green). Aging genes in orange are those whose loss of function leads to a decrease in the glp-1ts lifespan, and genes in blue are those whose loss of function decreases the lifespan. Their corresponding survival curves are shown in the bottom panel. The middle panel plots Pearson's correlation between shared targets and a novel aging gene (Y axis) and age-1 or daf-16 (X axis) (Table S16). The bottom panel presents the survival curves of glp-1ts worms grown at 25°C upon the knockout of the 6 novel aging genes (blue/orange), age-1 (green) or daf-16 (red) (Table S12). Control animals fed with an empty vector are shown in black. pvalues were calculated using a logrank test.
(C–D) show a lifespan epistasis experiment where sup-37 and sdc-3 RNAi was fed to either glp-1ts (C) or glp1ts; daf-16(mu86) (D) from L1 at 25C. The epistasis was evaluated with a Mantel-Cox logrank test. To evaluate the pvalues of 3 biological replicates we used a Fisher test (Table S20).
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| N, N′-dimethyl-4,4′-bipyridinium dichloride | Sigma | Item No. M2254; CASNo: 75365-73-0 |
| L-(−)-Dithiothreitol | Sigma | Item No. D9760; CASNo: 16096-97-2 |
| 3-oxo-cholest-4-en-26-oic acid/ Δ7-Dafachronic acid | Cayman | Item No. 14100; CASNo. 23017-97-2 |
| C20H31O2⋅ Na Arachidonic acid | Cayman Chemicals | Item No. 10006607 CASNo. 6610-25-9 |
| N, N′-dimethyl-4,4′-bipyridinium dichloride | Sigma | Item No. M2254; CASNo: 75365-73-0 |
| Power SYBR Green Cells-to-Ct kit | Invitrogen | Item No. A25599 |
| 96.96 Dynamic Array IFC | Fluidigm | Item No. SKU 100-6173 |
| Time-series RNA-seq | Generated in house | GEO accession: |
| DAF-12 ChIP-ChIP datasets in young adult worms | GEO accession: | |
| HSF-1 ChIP-seq datasets in young adult worms | GEO accession: | |
| Curated physical prior dataset | Raw data taken from public databases | Zenodo repository |
| Network related and experimental datasets | Generated in house: TF-gene interactions valid in young adult C. elegans (day 1 until day 4 adulthood) | Zenodo repository |
| Gene interaction database based on qRTPCR experiments | Generated in house: 5,497-edge gene interaction network (both positive and negative edges) from 19 novel ageing genes and 10 randomly selected regulators ( | Zenodo repository |
| Caenorhabditis Genetics Center | WB strain: | |
| Caenorhabditis Genetics Center | WB strain: | |
| Caenorhabditis Genetics Center | WB strain: | |
| Caenorhabditis Genetics Center | WB strain: | |
| This study | strain:MOC269 | |
| This study | strain:MOC267 | |
| This study | strain:MOC274 | |
| This study | strain:MOC313 | |
| This study | strain:MOC308 | |
| Caenorhabditis Genetics Center | WB strain: | |
| Caenorhabditis Genetics Center | WB strain: | |
| Caenorhabditis Genetics Center | WB strain: | |
| Caenorhabditis Genetics Center | WB strain: | |
| Caenorhabditis Genetics Center | WB strain:AGD1048 | |
| glp-1 | Caenorhabditis Genetics Center | WB strain: MAH42 |
| OL010 R sma-10 | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL011 F bcat-1 TCCCGGAGCAAAAGTTCTTCA | ||
| OL012 R bcat-1 TTCTGGACGGAACATGCGAA | ||
| OL015 F elo-1 ACACGAAACGATTTGTGGCTA | ||
| OL016 R elo-1 AGGATTGAAGCCTGAATAGTAACAT | ||
| OL017 F ech-8 GGCTCAGTGGTCTCTTCCAAAT | ||
| OL018 R ech-8 GCGATTGCAATTCCTCTTCCC | ||
| OL009 F sma-10 AAGTTGCAAGTCTACCAAGCG | ||
| OL019 F gba-4 GGATTTGGAGCTGCATTCACTG | ||
| OL020 R gba-4 CCCGAGACCATCATCGGAAAA | ||
| OL021 F ttx-3 AGGGTTCTGCAGGTTTGGTT | ||
| OL022 R ttx-3 ATTGATGCCAATGGGGCAGA | ||
| OL023 F asp-3 ACGATGTTGTCTGCTTCGGA | ||
| OL024 R asp-3 AGCGACGAAGGTGATTCCTG | ||
| OL025 F acs-7 ATCGGGTACAACTGGAAAACCA | ||
| OL026 R acs-7 CGTTGGCATCGAAGAATCTCA | ||
| OL027 F lpr-3 TAGGACAGGTTGTCCCACCA | ||
| OL028 R lpr-3 GGGAGGGCAATTGGTTGTTG | ||
| OL029 F lin-3 ACTACTGTCATCACAACGCGA | ||
| OL030 R lin-3 AACCCTGTGGACAATGGCAA | ||
| OL035 F best-17 CTGGATGAAGGTGGCAGAGG | ||
| OL036 R best-17 ATCGCCATGCCTCTCGAAAT | ||
| OL041 F daf-2 GGAAGAAGAGAATCTCGGCCC | ||
| OL042 R daf-2 CGAGCTTCGCTGCTGCTTA | ||
| OL043 F nduf-6 CGGACAAGCGTGGGATCAAT | ||
| OL044 R nduf-6 AATCCTCTGGAGGGCGTTGA | ||
| OL047 F nuo-6 | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL048 R nuo-6 GCAGAAATTCGGTCTTTCCGTG | ||
| OL051 F nhr-62 (Ver.2) ACCTGGTATGCGTAGTCTGC | ||
| OL051 F nhr-62 (Ver.2) ACCTGGTATGCGTAGTCTGC | ||
| OL052 R nhr-62 (Ver 2) CCGGTTGTGCCAAACACTTC | ||
| OL053 F nhr-17 (Ver.2) TCATCCACACGGCGTTTTCT | ||
| OL054 R nhr-17 (Ver.2) AGCAACGT | ||
| OL55 F abu-11 AGGAGAATGTGTTCCTCCGC | ||
| OL56 R abu-11 GTTGGTTTGAGCTGGTTGGC | ||
| OL57 F fmo-2 TCGACATGGTCTTCTCTATGGC | ||
| OL58 R fmo-2 TGACGACTCATTCGTTTCGTG | ||
| OL61 F lpr-5 GGAGAAGCCACCGGATCAAT | ||
| OL62 R lpr-5 CCCTTTCCTTTCACCAAGGC | ||
| OL69 F gipc-2 GCCGTTCTAGAAGCCGATCA | ||
| OL70 R gipc-2 TGAAGCTAAAACGGCAGGCT | ||
| OL71 F nhr-76 TCGTAACGCCGTAGTGATGG | ||
| OL72 R nhr-76 CGAGAAGACCAGCCTCATGT | ||
| OL73 F cup-16 AGGAAGATCGCATCAGTTGGG | ||
| OL74 R cup-16 AGAGAGCACTTAACGGCTTCAA | ||
| OL75 F tatn-1 CGTATTACCCCACTTCCGGG | ||
| OL76 R tatn-1 GATCCTTGCGGTTTGGCTTG | ||
| OL81 F tre-5 CGAGCTAACGCAATTGACCG | ||
| OL82 R tre-5 CATTGTCCAGGCGCTGTTTC | ||
| OL85 F mak-1 AGCTATTGCCATTCCTGGAGC | ||
| OL86 R mak-1 TTTCGGCAACCGTATCAGGA | ||
| OL87 F hsp-70 CGATGAAGTTGTCTTGGTTGGG | ||
| OL88 R hsp-70 TGGAGCAGTTGAGGTCCTTC | ||
| OL89 F tnt-4 | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL90 R tnt-4 TGGACCTTTGGTGGATGTCTT | ||
| OL91 F nhr-23 GCCAATACTGCCGTCTCAAA | ||
| OL92 R nhr-23 TGCATTCGAACCTCATCTTCT | ||
| OL93 F aagr-4 ACCAAGCAGGAGCTTTCCAG | ||
| OL94 R aagr-4 AGCTTCAGTTGTGTTGTCTGC | ||
| OL97 F pqn-13 AACTTGCGGACAACAAGCTC | ||
| OL98 R pqn-13 AGGTTTGCTGGCACTGTGG | ||
| OL99 F faah-2 GTATCGCCAGCTCTTCCACA | ||
| OL100 R faah-2 ACAGATCCTGCAGCATAATCCA | ||
| OL101 F abu-13 GTGAAGCAATGTCGCAAGGG | ||
| OL102 R abu-13 GCTCGGCGAGTTCTCTATCC | ||
| OL107 F F56F10.1 CCTCCATTCGATGCAAACACA | ||
| OL108 R F56F10.1 TGTGCTGTTGCTCTGTCCAT | ||
| OL109 F clec-186 AGCCTGTCCACAAGGATTCG | ||
| OL110 R clec-186 CGGAGCATCATCCGGTACAT | ||
| OL111 F nas-36 AGCAAAATCTACCGATGCCGA | ||
| OL112 R nas-36 CACCCCAATCTGCCCATACA | ||
| OL115 F dlat-1 CGCCAAAAGCTCAGGACTTG | ||
| OL116 R dlat-1 TGCTTTGGCAGATTTCCACTG | ||
| OL117 F cnp-3 CACTTCCAATGCCACCACAATC | ||
| OL118 R cnp-3 ATACGGCATCATTGGAGGCA | ||
| OL119 F R08B4.3 GCAGTCGTCATATGGGATGGT | ||
| OL120 R R08B4.3 AGCGTATCGACGTAGTCTGC | ||
| OL121 F Y14H12B.1 TGCACATGGGATGGTTGTGA | ||
| OL122 R Y14H12B.1 CCGCGTCGATGGAATCTCAG | ||
| OL123 F mccc-1 GCAGGTACCGTCGAGTTCAT | ||
| OL124 R mccc-1 | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL125 F C25H3.9 AGGACTATCCAACAGAACCACA | ||
| OL126 R C25H3.9 TTCGTGGTGCTCAACATCCG | ||
| OL127 F dpyd-1 AGATGACAACGGCAAGTGGT | ||
| OL128 R dpyd-1 AAAGCCGACAAAACTGCGTC | ||
| OL129 F mlc-3 CGGACAGGAGTTCAAGCGTA | ||
| OL130 R mlc-3 GGTTCCTTGCTCCTTCTCCT | ||
| OL131 F aqp-7 TATCTTCGGAGCCTGGTCCT | ||
| OL132 R aqp-7 GTCGGTGGCAAGTTTCAGTG | ||
| OL133 F K12C11.1 TGCTAGTAAAATCGCGTCGGA | ||
| OL134 R K12C11.1 TGTGACGGAACAGACTCTCC | ||
| OL135 F fbxa-85 GCTGATCCCAATCCAGAGATTAGT | ||
| OL136 R fbxa-85 TTGCCATGCTCAATTGCGAG | ||
| OL137 F unc-10 GCCAATGTTGGCTTCCAGTG | ||
| OL138 R unc-10 TCTCCTAGCACCGGTGAGG | ||
| OL141 F phb-2 CACTCAACGCCAACAGGTTT | ||
| OL142 R phb-2 GCTCGGTGAGGGAAACATCA | ||
| OL143 F hpl-2 CCACCGGGACATCGAATTCTT | ||
| OL144 R hpl-2 CGGTTTGCGCTTCAGTCATC | ||
| OL145 F prdx-3 TCTGGAACTGTCCGTCACAC | ||
| OL146 R prdx-3 GGCAAACCTCTCCGTGCTTA | ||
| OL147 F haf-9 AGGAAGCCAAATGTCAGGAGG | ||
| OL148 R haf-9 TCAGCGTCCAAAGCAGATGT | ||
| OL149 F nuo-5 GAATGAGATCGCTCCCCACC | ||
| OL150 R nuo-5 GGGAGACGTCAACGTCGATT | ||
| OL153 F egl-9 GTGTACATATTGTGGAAGCTCGTG | ||
| OL154 R egl-9 CAATCGAGTTGCTGGTGCTC | ||
| OL155 F grl-16 | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL156 R grl-16 TCGAGGTTGTCCTTCTCGTTC | ||
| OL157 F coq-5 AGACATTCGCCTACCGCAAA | ||
| OL158 R coq-5 CGCGAGATGGTTGGATATCTCT | ||
| OL159 F asp-14 CAACCAAGCAAAGTCGTCGT | ||
| OL160 R asp-14 CGGTCTCCGATCACAACAGT | ||
| OL161 F Y69A2AR.18 CAACCTCAGAGCTGCCTGC | ||
| OL162 R Y69A2AR.18 GGAAAATTGGGGCGTCGAAA | ||
| OL163 F abu-10 TATTGTCGCCCTGGCACTTT | ||
| OL164 R abu-10 GATGGTGGATTGTTGGCAGC | ||
| OL165 F rmh-2 GATGGATGTCACCCGTCGAA | ||
| OL166 R rmh-2 GCAGGACACTGGTTCCTCAT | ||
| OL167 F immt-1 ACGAGCTCTTGTGGAAAGCC | ||
| OL168 R immt-1 GAGTCCGGATGACTTGCTCC | ||
| OL169 F f17h10.1 AGCTTACAGACCCGATCCGA | ||
| OL170 R f17h10.1 TGGCGAGAAGACCTCCCATA | ||
| OL171 acd-1 F ACTGATGGACACATGAGAGCAA | ||
| OL172 acd-1 R TCACTGAGAAGTTGCGTGACA | ||
| OL173 ahcy-1 F CTGCAACGTTGGTCACTTCG | ||
| OL174 ahcy-1 R GTAACGGTCAACCTGTGGCT | ||
| OL175 art-1 F ACAAATCGCCTGGAAGACTGT | ||
| OL176 art-1 R GTAGCATTGACAGCGGCTTG | ||
| OL177 atp-2 F AGTCGCTGAGGTGTTCACTG | ||
| OL178 atp-2 R GGTGGTCGAGTTCTCCCTTG | ||
| OL179 asp-17 F TGGGGTCACTTATGTTCCGC | ||
| OL180 asp-17 R CCGTGTCGGAAATTACCTGATTG | ||
| OL183 bli-6 F GGCTTCAGAAATGGAGGTGGA | ||
| OL184 bli-6 R | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL185 clec-265 F ACACAAACTTTGCAGTTGGAGA | ||
| OL186 clec-265 R AGAATCTGGGCATGGCTGAG | ||
| OL187 bli-1 F TGCCCAGAACTATCCAAGGTTT | ||
| OL188 bli-1 R CCGGCTCTCTACCGTAATTGT | ||
| OL189 clec-75 F GGTGTTCAGCCAATCTCCGA | ||
| OL190 clec-75 R GCAAACGGCACTAGATAACACA | ||
| OL191 col-109 F GATCGCTGGAAACCTGACCA | ||
| OL192 col-109 R AGGCTTTCCGTTACGTCCTG | ||
| OL193 dld-1 F GTCGCTGTCCAGAACGACT | ||
| OL194 dld-1 R GACGAGATCGGCATCTTGAGT | ||
| OL195 dod-19 F TGGGCAGAAAACACTCCTTGA | ||
| OL196 dod-19 R GCTGTAATCAGATAGGCGGACT | ||
| OL197 fkb-1 F GCGTTCAGAAATCCAGAAAGGG | ||
| OL198 fkb-1 R ATTCTTCATTGCGAGTGCGG | ||
| OL199 folt-2 F GGCCACAGTTTGTGGTCTATTC | ||
| OL200 folt-2 R CGTTTTGAAAAACCGCCTGC | ||
| OL201 grsp-2 F GCTCAGGGATCCCCAGGTC | ||
| OL202 grsp-2 R CCATCCTCCAGATGAACCGA | ||
| OL203 lec-10 F TATCACAACCCCGGTGTCC | ||
| OL204 lec-10 R TTCTTGTGATGTCCGTGACGA | ||
| OL205 lips-15 F GGGTCAGCAACCTTGAATGC | ||
| OL206 lips-15 R GTGTTCGGGTAGTGGGACTG | ||
| OL207 lpd-5 F CTGGAACTGCGGATCCACTC | ||
| OL208 lpd-5 R CTCCTCGACGTCAAACTCCC | ||
| OL209 dpy-13 F ATCGCCGTGCTTTCGGTTT | ||
| OL210 dpy-13 R CTTGCAGGTAAGGGCTTCGT | ||
| OL211 ell-1 F | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL212 ell-1 R AGTGTCACGTGATGGTGGTG | ||
| OL213 mec-12 F TCGGAGGATCCGATGACTCT | ||
| OL214 mec-12 R GCGGATTTCGTCAATGACAGT | ||
| OL215 mec-7 F GCAATCAGCAGTATCGTGCC | ||
| OL216 mec-7 R CAGCGGTGAGATAACGTCCA | ||
| OL217 mrpl-32 F ACTGCACAAAACTTGCCAATGA | ||
| OL218 mrpl-32 R GCGAGTTACTTTCTTTGGTTTGC | ||
| OL219 mrpl-4 F GGACTTTGTGTTGCTCTCACTC | ||
| OL220 mrpl-4 R GAGCTTCGCAAAGATCAATCCA | ||
| OL221 mrps-26 F CTGCCATGTCACAAATGGACG | ||
| OL222 mrps-26 R TAGAGAACT | ||
| OL223 mrps-30 F AGGAAGCTAAACAAATGCTCGAC | ||
| OL224 mrps-30 R TGAATCCATGAGTGTGAGCTTGA | ||
| OL225 oxy-5 F TCGGCCCAGTTGGAAAGATT | ||
| OL226 oxy-5 R AGCCAGTATTAACAGCCTCACA | ||
| OL227 pat-10 F CCGACAACATGGCTGAGGAT | ||
| OL228 pat-10 R GCTTTCCTCTGTCGAAGGCA | ||
| OL229 rack-1 F GAAGCTTACCGGAACCCTCG | ||
| OL230 rack-1 R GTCTTGTCGCGGGAAGATGA | ||
| OL231 rla-0 F GCTTGTCGAGCTTTTCGAGG | ||
| OL232 rla-0 R TCAGCATGTCCTCTCATGGC | ||
| OL233 rol-8 F ACGGTAGAGATGCTGAGGTT | ||
| OL234 rol-8 R ATTGGTCCTATAGCTCCCATTG | ||
| OL235 rpl-3 F GGATACGTCGACACCCCAC | ||
| OL236 rpl-3 R CTTGGATTTAGCCCAGTTGCTG | ||
| OL237 rps-11 F GTCGTTCGTCGTGACTACCT | ||
| OL238 rps-11 R | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL239 rps-28 F AGAAACGTTAAGGGCCCAGT | ||
| OL240 rps-28 R AGTCGAGACCGACACTTAGC | ||
| OL241 rps-9 F CAGGCTCCAAACCCAGGTC | ||
| OL242 rps-9 R TTGTCTGCGGACACGGATG | ||
| OL243 sdha-2 F AGGAAGAGGAGTCGGACCAA | ||
| OL244 sdha-2 R GGTTTCCGAGATTCCTGGCA | ||
| OL245 sol-2 F TGCAGTGGAGGGTCTGATTG | ||
| OL246 sol-2 R TCCATGACCCTGTTCAACACA | ||
| OL247 taco-1 F AGAAGGGGCACTCGAAATGG | ||
| OL248 taco-1 R CTGCTCCACGGACCTTTCTG | ||
| OL249 tfg-1 F GCCAACGACTTGACACTCATC | ||
| OL250 tfg-1 R TGTCACCAAATCGCCTTCTTC | ||
| OL251 trap-1 F GCCAATGTTGTTCGCGAGTT | ||
| OL252 trap-1 R GTCTCAGCGTACTTCACGACA | ||
| OL253 tufm-1 F ACAAAGATCCTCGCCACATCA | ||
| OL254 tufm-1 R TTGATGGTGATACCACGGGC | ||
| OL255 ugt-25 F CAGTACTAGACGAACGACCACA | ||
| OL256 ugt-25 R CTCCAGCAGTCCATTTCTCCA | ||
| OL257 unc-62 F GGCATCCGATGGAGGGATCA | ||
| OL258 unc-62 R GTCCCCTGCTTGGTTGGAAG | ||
| OL259 unc-69 F AGTGCTCGGCCAGTACATT | ||
| OL260 unc-69 R AAAATCGTCGTCGTGAATGCT | ||
| OL261 vdac-1 F CGGATGGAAGGTTGGTGGAA | ||
| OL262 vdac-1 R CAACGGCAACTTGGGAAGAG | ||
| OL263 vhl-1 F TGGCTGAATCCATCAAAACAACC | ||
| OL264 vhl-1 R CTCCTAGCAACCCATGGATGA | ||
| OL265 trp-4 F | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL266 trp-4 R GGGTCATGCATCTCAACCGA | ||
| OL267 vap-1 F CGGCTGCTCTAACACCAAGA | ||
| OL268 vap-1 R ACTTGTTTGGCTCAAGCCCT | ||
| OL269 mct-4 F GGCGGGAGGATTGATCTCTG | ||
| OL270 mct-4 R CAAGACCTCCCATCACTCCG | ||
| OL271 gst-10 F ACTTCACTATTCGAGGATTCGGA | ||
| OL272 gst-10 R CTTGCCATTCATTCCCCTCG | ||
| OL273 sams-3 F CGCTGAGAACGGACACTTTG | ||
| OL274 sams-3 R CCGTTTGAGATCGTTTTTCCTCC | ||
| OL275 B0491.5 F CGTGGCTACCATGAAGAGCA | ||
| OL276 B0491.5 R TTGGAGTCCAGTCTCCGAGT | ||
| OL277 C12D12.1 F CCGTTACAGTGCCGACTACA | ||
| OL278 C12D12.1 R TGGTTTGCTTACTTGTGCCA | ||
| OL279 C17F4.7 F TTTGCACACAATTGCCCGTT | ||
| OL280 C17F4.7 R TAGGGCTTATGCGCAGCC | ||
| OL281 C18D11.1 F TCGGATTGCAGTTCCTCCAC | ||
| OL282 C18D11.1 R CCACGGACGTCGTACACTTT | ||
| OL283 C40H1.8 F ATTGGTCTGTACAAGCCGGA | ||
| OL284 C40H1.8 R TGTACGGGAAAGTTTTGGTATGC | ||
| OL285 C55A6.7 F GTAACCGGATCCAATCGAGGA | ||
| OL286 C55A6.7 R TGAGAGCAGTTGCCTTATCAAC | ||
| OL287 dlat-2 F | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL288 dlat-2 R GGAGTGATAAGGCCGGTTGG | ||
| OL289 C55B7.3 F TGTGACTCTGAGACTGCTCCA | ||
| OL290 C55B7.3 R ACACTTGTTGAGAACCGAGTGA | ||
| OL291 cpt-3 F GTTGGCGAAAATCGTCTCCG | ||
| OL292 cpt-3 R CGGTTTTTGCTCCATTCGGT | ||
| OL293 dct-8 F GCTTCCTTCGCAACCTCATTG | ||
| OL294 dct-8 R TTTCCATACATATTTCCTCCGGCA | ||
| OL295 eef-1A.1 F ATCACTGGAACATCCCAGGC | ||
| OL296 eef-1A.1 R CGCGAGTTTGTCCGTTCTTG | ||
| OL297 F23C8.5 F TGCTGTCAAGATCCGTGTCAA | ||
| OL298 F23C8.5 R TTGACGGCCTCCTCTAAAGC | ||
| OL299 F26G1.2 F GAAGAACGCGAGAAAGTGCG | ||
| OL300 F26G1.2 R CGTTGGATTCTTGCCCGATG | ||
| OL301 F33G12.6 F CTGCTGACGACATAAGAGGTGA | ||
| OL302 F33G12.6 R CGATTCGATCCCAACATGCTTC | ||
| OL303 fkb-7 F TATGCCAGGACTTGATAAGGGTC | ||
| OL304 fkb-7 R TGCTCTTGCTCTTTCTGCTCA | ||
| OL305 brp-1 F CTTCAAGAAAACCGAAACATCCG | ||
| OL306 brp-1 R TCCTGGATTTTCCGCAGAGTT | ||
| OL307 T19C9.8 F GTGTAGCTAGTTACCATGCTGGA | ||
| OL308 T19C9.8 R AACTTGGATTTGGTACCGGTGT | ||
| OL309 T21H3.1 F CCGTCAGTCCACAGGACAAG | ||
| OL310 T21H3.1 R GCAGCCCATGGAGTGTGAT | ||
| OL311 Y26D4A.21 F AAAATGTAAGAT | ||
| OL312 Y26D4A.21 R CTCGTCCGATTGAATTGCCTG | ||
| OL313 Y51H7C.13 F GCTATTGGAACCAAGTGCTGC | ||
| OL314 Y51H7C.13 R | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL315 Y54F10AM.5 F TCTTTGAAGCGTTCCTGCCT | ||
| OL316 Y54F10AM.5 R TGGTCGTCATGGCACTTTGA | ||
| OL317 Y51H1A.3 F GGAATTGGGGAGAGCTCGTG | ||
| OL318 Y51H1A.3 R CGATCGAGTTCCAGGTGGTG | ||
| OL319 Y71G12B.10 F GTTATGAGGTCTCGCTGGGC | ||
| OL320 Y71G12B.10 R GTTTTTCGGCTGGCACACTT | ||
| OL321 Y43F8B.1 F CGAGCAACTAGCCCAGAAGT | ||
| OL322 Y43F8B.1 R GAGCTCGGAATCAGCTACCC | ||
| OL323 lpl-1 F AGGTGTTAGGCATTTTGTGGAC | ||
| OL324 lpl-1 R ACCCATACACCTGTATTCGCA | ||
| OL325 atp-1 F AAACCGGAAAGACCGCCATT | ||
| OL326 atp-1 R GACAGCGACGTAGATGCAGA | ||
| OL327 mdh-2 F CTTCCAGCAAAGACCCTCGT | ||
| OL328 mdh-2 R AGAAGAGCGACCTTTGGAGC | ||
| OL329 paf-2 F AGTTGGTCATGTCATCCGCT | ||
| OL330 paf-2 R TTGCTTTTTGGAAGTCCGTTGT | ||
| OL331 str-7 F TTTCACATCAAACGGCAATTCG | ||
| OL332 str-7 R GGAGGAACGTGTGAAACAAGTAT | ||
| OL333 tag-120 F TATTTTCACTCTCTCGGCAGCA | ||
| OL334 tag-120 R TCCACTGCATACTGTGGTGAT | ||
| OL335 sucl-1 F GGGAGCTGCTCGTTTCTACA | ||
| OL336 sucl-1 R AGGTACCCTGCTTTCCTGTG | ||
| OL337 tald-1 F GAATTCGGGCTGCTAACACG | ||
| OL338 tald-1 R GGCGAGATTAGGGTGACTCC | ||
| OL339 tiam-1 F CCTTGTGATGAGCAGCCAGA | ||
| OL340 tiam-1 R ACGCGAAACATTCCAGCAAAT | ||
| OL341 rhy-1 F | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL342 rhy-1 R TTCGAGGATCTTTCAGTGAGCA | ||
| OL343 dpy-2 F GAATTTTGTCAGGCATCCGCA | ||
| OL344 dpy-2 R ATCCAGCAGCCCTTTTCGTT | ||
| OL345 C16C10.4 F TGCATA | ||
| OL346 C16C10.4 R TCTGCCTGCACAATAGCGAA | ||
| OL347 glf-1 F CCGTGTCACAATTCTCAGCAG | ||
| OL348 glf-1 R TCTCTTCCTCGGTGATCGGA | ||
| col-129 F TCAATGATGTCAACAATTACTATGATGA | ||
| col-129 R GCCAGACGGTATTAGCATCG | ||
| OL335 sucl-1 F GGGAGCTGCTCGTTTCTACA | ||
| OL336 sucl-1 R AGGTACCCTGCTTTCCTGTG | ||
| OL337 tald-1 F GAATTCGGGCTGCTAACACG | ||
| OL338 tald-1 R GGCGAGATTAGGGTGACTCC | ||
| OL339 tiam-1 F CCTTGTGATGAGCAGCCAGA | ||
| OL340 tiam-1 R ACGCGAAACATTCCAGCAAAT | ||
| OL341 rhy-1 F TGACACTTGTCGTCATCGGAA | ||
| OL342 rhy-1 R TTCGAGGATCTTTCAGTGAGCA | ||
| OL343 dpy-2 F GAATTTTGTCAGGCATCCGCA | ||
| OL344 dpy-2 R ATCCAGCAGCCCTTTTCGTT | ||
| OL345 C16C10.4 F TGCATACTTG | ||
| OL346 C16C10.4 R TCTGCCTGCACAATAGCGAA | ||
| OL347 glf-1 F CCGTGTCACAATTCTCAGCAG | ||
| OL348 glf-1 R TCTCTTCCTCGGTGATCGGA | ||
| col-129 F TCAATGATGTCAACAATTACTATGATGA | ||
| col-129 R GCCAGACGGTATTAGCATCG | ||
| acdh-11 F TAATGCAGTCGCATCGTTGG | ||
| acdh-11 R | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| acdh-1 F TCCGAGCTTCATCCACTTGT | ||
| acdh-1 R TGCGTATTTGTAGCCTTTTCCA | ||
| acdh-8 F CCGCAGCTGAAGTTGACTCT | ||
| acdh-8 R CCTCCGAAGATCTGACAAGCA | ||
| acs-5 F GGGAGAATACGTGGCACCAG | ||
| acs-5 R AGCGATGAGCCATCTTTCCA | ||
| aip-1 F CTGGACGGATTCAATCACATC | ||
| aip-1 R TTGTAGAGAACGAGCCAGAGC | ||
| atg-18 F AGCCGCAAGGAGTAATCAAGTATC | ||
| atg-18 R TCCGTCTGATGTAGCAGCCAT | ||
| cct-4 F CAGCCACGACGATAATACAACAG | ||
| cct-4 R CAGGCGGTAGAGCAGGAAGT | ||
| cpt-4 F CGAGAACAGAGACGCTACGC | ||
| cpt-4 R TTCAACAGGTCTCTTCGCTCTT | ||
| cth-1 F GGAGCCGCTATCACTAATAATGAC | ||
| cth-1 R CGAATGGAGATGGAACACCT | ||
| dnj-11 F AGCAAGCCGACAAGGAGACA | ||
| dnj-11 R CATCTCTCCACGGTTCCAGGT | ||
| dod-17 F ATTCACACTCACTGTCGCTAACG | ||
| dod-17 TCGGTCCTGTGCTGTATTCGR | ||
| ech-6 F TCTATGCCGGAGAGAAGGCT | ||
| ech-6 R AACGCTGAGTACCTCCTGCT | ||
| elo-5 F ATGCACTGGTACCATCACGC | ||
| elo-5 R ACCCAAACCATATGGACAGCA | ||
| ets-4 F TCTCAAAGGACGCCGATCAC | ||
| ets-4 R CTGGGTGTCAAGACCGTTGT | ||
| fat-2 F | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| fat-2 R GAGGACAAAGGCAATGTAAGCA | ||
| fat-4 F AGTTTGCATTGAGCTCGAACAT | ||
| fat-4 R CCTCCCCAAAGCCAGTCAAT | ||
| fat-7 F GCCGTCTTCTCATTTGCTCTC | ||
| fat-7 R CTCATTGGTGTGGTTGCCTT | ||
| lbp-8 F GAGAGAAATTTGTTGAAATTGCTCCG | ||
| lbp-8 R TGAAAACAGAGCTGTGGTGGT | ||
| lbp-9 F TCGTGATGTGTCGAGCGTC | ||
| lbp-9 R ACGATGACGAGCTTTCCGTT | ||
| let-767 F GCAGCTGTGGCTTATCGTCT | ||
| let-767 R CGGTGACAACAGCCCAAGAA | ||
| lipl-4 F TGATGACTGTAATGATCCCATTGT | ||
| lipl-4 R CCATGATTTTATTAATTCCGGCGTA | ||
| mex-1 F TCGCAGAGCCACCAACAAGA | ||
| mex-1 R GATGAGGAAGAGGACCGATGC | ||
| mtl-2 F TGGTCTGCAAGTGTGACTGC | ||
| mtl-2 R GGCAGTTGGGCAGCAGTATT | ||
| nhr-80 F ATCACCGACGAGATCATGCC | ||
| nhr-80 R TCGAAACCCCCTTGAAAGC | ||
| oma-1 F CCAAGATATGAGCTACCAACGAA | ||
| oma-1 R CAGCGAGACGGTGGATAGGT | ||
| sbp-1 F ATCCGATTGGATTGCTCGCT | ||
| sbp-1 R GAGTGCTAGTTCCATCCGGG | ||
| sip-1 F CGGGTTCAGCAAGAGATCGT | ||
| sip-1 R CCAAGTCGACGTCCTTTGGA | ||
| tcer-1 F TGAGCCACGAAAATCAGGAGAA | ||
| tcer-1 R | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| vit-1 F AGCCAGAAGAAATCCGATCTTG | ||
| vit-1 R GCTCCACAGCTTCGTATCCA | ||
| vit-2 F TCCATCAAGAGCCACATCAAGA | ||
| vit-2 R CGAACTCAGCCTTGTCTCCA | ||
| cdc-42 F TCCACAGACCGACGTGTTTC | ||
| cdc-42 R TCCACAGACCGACGTGTTTC | ||
| pmp-3 F gttcccgtgttcatcactcat | ||
| pmp-3 R acaccgtcgagaagctgtaga | ||
| ire-1 F TACTTGCCACCACGGAGACC | ||
| ire-1 R CGTTGCCATCGTCATCATTG | ||
| OL001 F mdh-1 GAACCAAGGCTGGGCAATTC | ||
| OL002 R mdh-1 ACCCTCGATGGTAACTGGGA | ||
| OL003 F sams-1 CCAGCATTGGATTCGACCAC | ||
| OL004 R sams-1 TCCGACATCTTCTCCGTCCT | ||
| OL005 F far-3 GAGCTCATTGCTGGAGGACG | ||
| OL006 R far-3 TGCAGCAACTTGGGTTTCAAT | ||
| OL007 F sma-4 ATATCCGTTATTACCTCAAATGCCA | ||
| OL008 R sma-4 AGAAGACGCTTCGTCAAGAG | ||
| OL009 F sma-10 AAGTTGCAAGTCTACCAAGCG | ||
| OL010 R sma-10 CCGGTCTTGGAGTTCCTGTG | ||
| OL011 F bcat-1 TCCCGGAGCAAAAGTTCTTCA | ||
| OL012 R bcat-1 TTCTGGACGGAACATGCGAA | ||
| OL015 F elo-1 ACACGAAACGATTTGTGGCTA | ||
| OL016 R elo-1 AGGATTGAAGCCTGAATAGTAACAT | ||
| OL017 F ech-8 GGCTCAGTGGTCTCTTCCAAAT | ||
| OL018 R ech-8 | All oligos were designed in house | Does not apply to any oligos in this list/ NA |
| OL009 F sma-10 AAGTTGCAAGTCTACCAAGCG | ||
| OL019 F gba-4 GGATTTGGAGCTGCATTCACTG | ||
| RStudio Version 1.2.5033 | ||
| R language Version 3.6.3 | ||
| Prism | GraphPad | |
| Cytoscape version 3.8.2 | ||
| Python version 3.8 | Python Software Foundation | |
| Inferelator 2.0 | ||
| MERLIN-P | ||
| Time-lagged LASSO | ||
| SeqMonk | ||
| Stochastic Block Model | ||
| max AUFE | TO/FROM | Input | core | output |
|---|---|---|---|---|
| input | 18417 | 571 | 0 | |
| core | 249216 | 8428 | 0 | |
| output | 735 | 34526 | 1446 | |
| input | 41287 | 761 | 0 | |
| core | 226597 | 1438 | 0 | |
| output | 164 | 8019 | 112 | |
| input | 15026 | 474 | 0 | |
| core | 247117 | 7681 | 16 | |
| output | 209 | 9218 | 126 |